Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|CCG-203971||CCG-203971 is a small molecule inhibitor that blocks the activity and nuclear localization of MRTF-A, thereby possibly resulting in mitigation of cell migration and metastasis, and decreased tumor growth (PMID: 27837031, PMID: 32665796).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||melanoma||not applicable||CCG-203971||Preclinical - Cell line xenograft||Actionable||In a preclinical study, a melanoma cell line treated with CCG-203971 resulted in inhibition of cell migration, invasion, and decreased cell growth in culture, and a reduced tumor burden in xenograft models (PMID: 27837031).||27837031|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|